Yahoo · Oct 14, 2026
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Smart Beta ETF report for IBD
NYSE · IBD
Inspire Corporate Bond Impact ESG ETF
Financial Services · Asset Management - Bonds
$23.15
Up+$0.04 (+0.17%)
Updated Oct 30, 2026, 1:29 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 450.75M
- P/E ratio
- —
- Dividend yield
- 4.35%
- 52-week range
- $22.50 – $24.78
- Volume
- 56.27K
- Avg. volume
- 60.58K
Price performance · IBD
IBD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
IBD closed at $23.15 after 21 trading sessions, up 0.61% for the selected period.
- Last close
- $23.15
- Period change
- +0.61%
- Period low
- $23.01
- Period high
- $23.30
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $23.17 | $23.21 | $23.125 | $23.15 | 56.27K |
| Oct 28, 2026 | $23.20 | $23.2489 | $23.11 | $23.11 | 61.04K |
| Oct 27, 2026 | $23.30 | $23.31 | $23.2501 | $23.26 | 79.5K |
| Oct 26, 2026 | $23.26 | $23.29 | $23.23 | $23.26 | 48.52K |
| Oct 23, 2026 | $23.32 | $23.45 | $23.18 | $23.23 | 464.58K |
| Oct 22, 2026 | $23.23 | $23.33 | $23.185 | $23.30 | 65.64K |
| Oct 21, 2026 | $23.15 | $23.71 | $23.1272 | $23.16 | 101.74K |
| Oct 20, 2026 | $23.20 | $23.29 | $23.0904 | $23.17 | 59.57K |
| Oct 19, 2026 | $23.16 | $23.60 | $23.05 | $23.05 | 678.6K |
| Oct 16, 2026 | $23.13 | $23.70 | $23.13 | $23.23 | 133.15K |
| Oct 15, 2026 | $23.20 | $23.25 | $23.14 | $23.19 | 134.68K |
| Oct 14, 2026 | $22.96 | $23.50 | $22.815 | $23.15 | 63.23K |
| Oct 13, 2026 | $23.09 | $23.31 | $22.99 | $23.06 | 109.8K |
| Oct 12, 2026 | $23.05 | $23.0988 | $22.665 | $23.06 | 197.84K |
| Oct 9, 2026 | $23.04 | $23.56 | $22.50 | $23.17 | 425.75K |
| Oct 8, 2026 | $23.00 | $23.125 | $23.00 | $23.05 | 56.57K |
| Oct 7, 2026 | $22.97 | $23.5182 | $22.76 | $23.05 | 43.38K |
| Oct 6, 2026 | $23.02 | $23.325 | $23.015 | $23.12 | 95.1K |
| Oct 5, 2026 | $22.99 | $23.28 | $22.95 | $23.01 | 113.53K |
| Oct 2, 2026 | $23.05 | $23.16 | $22.52 | $23.02 | 60.41K |
| Oct 1, 2026 | $23.01 | $23.08 | $22.4962 | $23.01 | 132.22K |
Latest IBD news
The latest Smart Investors Daily articles mentioning IBD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
IBD research
Overview
Company profile and research snapshot.
Company profile
The fund generally invests at least 80% of its total assets in the component securities of the index. The index provider selects domestic corporate bonds issued by companies that have market capitalizations of $5 billion or more, have credit ratings of BBB- or higher from Standard and Poor’s or Baa3 or higher from Moody’s and which have an Inspire Impact Score® of zero or higher.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Feb 2, 2026
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Smart Beta ETF report for IBD
SeekingAlpha · Jan 26, 2026
4 Key Market Signals To Watch
Investors could get nervous with each jolt of turbulence, whether geopolitical, political, or monetary. Or they could put the noise-cancelling headphones on and focus on the destination.
SeekingAlpha · Jan 26, 2026
The Bond Markets
US blue-chip companiesâ borrowing costs relative to Treasuries have fallen. The cost of borrowing for IG companies stands at 0.73 percentage points above the equivalent on US government debt
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
